News from the FDA/CDC

FDA issues new REMS for immediate-release opioids


Opioid prescribers will need to be mindful of a new, expanded Risk Evaluation and Mitigation Strategy issued Sept. 18 by the Food and Drug Administration, covering immediate-release opioid analgesics used in the outpatient setting. The strategy also applies to extended-release and long-acting opioids, which have been subject to REMS since 2012.

FDA icon

The new REMS program requires for the first time that training be made available to health care providers who are involved in pain management. For the purposes of this REMS program, the training is not limited to just the prescriber, but includes nurses and pharmacists.

REMS educational materials are now required to cover broader information about pain management, including alternatives to opioids for pain management.

The FDA said it is in the process of approving a new label for opioids that will contain information about health care provider education that is now a part of the REMS.

“Our new effort is aimed at arming providers with the most current and comprehensive information on the appropriate management of pain,” FDA Commissioner Scott Gottlieb, MD, said in a statement. “Appropriate prescribing practices and education are important steps that we are prioritizing to help address the human and financial toll of this crisis.”

Dr. Scott Gottlieb, commissioner of the Food and Drug Administration

Dr. Scott Gottlieb

Dr. Gottlieb added that the goal of the new REMS is to help prescribers with the latest evidence on the appropriate amount of doses that should be prescribed for a given condition and that the “aim is to reduce overall dispensing as a way to further reduce exposure to these drugs. Our goal is to help prevent patients from becoming addicted by decreasing unnecessary or inappropriate exposure to opioids and fostering rational prescribing to enable appropriate access to those patients who have legitimate medical need for these medicines.”

The FDA also approved a new guidance document that includes updated educational content.

Recommended Reading

NIH launches HEAL Initiative to combat opioid crisis
The Hospitalist
Do free meals to physicians affect opioid prescribing?
The Hospitalist
Data suggest harm outweighs benefit of opioids for musculoskeletal pain
The Hospitalist
Methamphetamine use climbing among opioid users
The Hospitalist
Fentanyl analogs nearly double their overdose death toll
The Hospitalist
Better ICU staff communication with family may improve end-of-life choices
The Hospitalist
Nearly one-quarter of presurgery patients already using opioids
The Hospitalist
How to prescribe effectively for opioid use disorder
The Hospitalist
Opioid use has not declined meaningfully
The Hospitalist
More than half of urine drug screens showed improper medication use
The Hospitalist
   Comments ()